Imaging activated T cells predicts response to cancer vaccines. The Journal of Clinical Investigation.Volume 128, Number 6, June 2018. Read more.
Assessment of pharmacology and toxicology of anti-CTLA-4 antibody (ADU-1604) in non-human primates and evaluation of local anti-CTLA-4 application. Aduro Biotech Europe, Oss, The Netherlands; and Aduro Biotech, Berkeley, CA, USA. Poster #1702, 2018. Read more.
Extremely stable high molecular mass soluble multiprotein complex from eggs of sea urchin Strongylocentrotus intermedius with phosphatase activity. Wiley, Journal of Molecular Recognition. 2018;e2753. Read more.
Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells. PLOS ONE. Navas, T. et al, 13 (6). 2018. Read more.